Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 09:29 am Sale | 13G | Climb Bio Inc. CLYM | Deep Track Capital LP | 2,169,143 3.230% | -1,735,642 (-44.45%) | View |
| 2024-08-16 4:23 pm Unchanged | 13D | Climb Bio Inc. CLYM | AI ETI LLC | 5,009,400 7.500% | 0 (Unchanged) | View |
| 2024-08-14 4:05 pm Purchase | 13G | Climb Bio Inc. CLYM | Affinity Asset Advisors LLC | 1,813,193 2.700% | 143,193 (+8.57%) | View |
| 2024-07-02 4:01 pm Purchase | 13G | Climb Bio Inc. CLYM | Deep Track Capital LP | 3,904,785 5.850% | 3,904,785 (New Position) | View |
| 2024-07-01 9:28 pm Purchase | 13D | Climb Bio Inc. CLYM | RA CAPITAL MANAGEMENT L.P. | 31,459,267 47.100% | 18,268,418 (+138.49%) | View |
| 2024-06-06 4:16 pm Purchase | 13D | Climb Bio Inc. CLYM | RA CAPITAL MANAGEMENT L.P. | 13,190,849 44.300% | 557 (+0.00%) | View |
| 2024-05-17 4:18 pm Purchase | 13D | Climb Bio Inc. CLYM | RA CAPITAL MANAGEMENT L.P. | 13,190,292 45.300% | 556 (+0.00%) | View |
| 2024-05-17 4:01 pm Unchanged | 13D | Climb Bio Inc. CLYM | AI ETI LLC | 5,009,400 17.200% | 0 (Unchanged) | View |
| 2024-05-07 6:01 pm Purchase | 13G | Climb Bio Inc. CLYM | Affinity Asset Advisors LLC | 1,670,000 6.020% | 1,670,000 (New Position) | View |
| 2024-04-12 6:52 pm Purchase | 13D | Climb Bio Inc. CLYM | RA CAPITAL MANAGEMENT L.P. | 13,189,736 47.500% | 10,555 (+0.08%) | View |
| 2024-03-18 4:46 pm Purchase | 13D | Climb Bio Inc. CLYM | RA CAPITAL MANAGEMENT L.P. | 13,179,181 47.500% | 2,778 (+0.02%) | View |
| 2024-02-07 11:53 am Purchase | 13G | Climb Bio Inc. CLYM | BML Investment Partners L.P. | 2,350,682 8.500% | 453,068 (+23.88%) | View |
| 2023-11-17 4:30 pm Purchase | 13D | Climb Bio Inc. CLYM | RA CAPITAL MANAGEMENT L.P. | 13,176,403 47.700% | 13,332 (+0.10%) | View |
| 2023-11-13 5:13 pm Unchanged | 13D | Climb Bio Inc. CLYM | AI ETI LLC | 5,009,400 18.500% | 0 (Unchanged) | View |
| 2023-04-10 5:01 pm Purchase | 13D | Climb Bio Inc. CLYM | RA CAPITAL MANAGEMENT L.P. | 13,163,071 48.800% | 11,112 (+0.08%) | View |
| 2023-03-08 4:00 pm Purchase | 13G | Climb Bio Inc. CLYM | Intermediate Capital Group plc | 2,002,563 7.500% | 2,002,563 (New Position) | View |
| 2023-02-14 2:22 pm Sale | 13G | Climb Bio Inc. CLYM | SAMLYN CAPITAL LLC | 0 0.000% | -2,128,202 (Position Closed) | View |
| 2023-02-08 4:35 pm Purchase | 13G | Climb Bio Inc. CLYM | BML Investment Partners L.P. | 1,897,614 7.100% | 158,236 (+9.10%) | View |
| 2022-09-22 5:02 pm Purchase | 13G | Climb Bio Inc. CLYM | ICG Life Sciences SCSp | 2,002,563 7.500% | 2,002,563 (New Position) | View |
| 2022-05-04 11:25 am Purchase | 13G | Climb Bio Inc. CLYM | BML Investment Partners L.P. | 1,739,378 6.500% | 1,739,378 (New Position) | View |